Inhibition of neointima formation in an organ culture of human saphenous vein: A comparison of dual endothelin-converting enzyme/neutral endopeptidase and selective neutral endopeptidase inhibition
Ke. Porter et al., Inhibition of neointima formation in an organ culture of human saphenous vein: A comparison of dual endothelin-converting enzyme/neutral endopeptidase and selective neutral endopeptidase inhibition, J VASC SURG, 34(3), 2001, pp. 548-554
Citations number
27
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
Purpose: Endothelin-1 (ET-1) has been implicated in a variety of vascular p
athologic conditions, although there is considerable controversy as to whet
her such effects are mediated by the ET-(A) or ET-(B) receptor. This study
investigated whether inhibition of big ET-1 processing by inhibition of end
othetin-converting enzyme (ECE) could, therefore, offer an alternative ther
apeutic strategy in the prevention of vein graft intimal hyperplasia.
Methods: Human saphenous vein (3 equal segments from 10 patients) were main
tained in organ culture for 14 days with either 50 mu mol/L CGS 26303 (a du
al ECE/neutral endopeptidase [NEP] inhibitor), 50 mu mol/L CGS 24592 (a sel
ective NEP inhibitor), or vehicle (control). They were then processed for i
mmunostaining and neointimal thickness measurements, and conditioned media
was collected for enzyme-linked immunosorbent assay analysis.
Results: Neointimal thickness in the ECE/NEP-inhibited veins did not differ
significantly from that of control segments. However, there was a highly s
ignificant augmentation in the NEP-inhibited segments, consistent with an i
nhibition of ET-1 degradation (median difference, 16.8; 95% CI, -23.5, -10.
4; P = .002, Wilcoxon). ECE immunostaining was reduced in the ECE/NEP-inhib
ited veins, although ET-1 staining was also present. ET-1 expression was in
tense in the thickened neointimas of NEP-inhibited veins, which also showed
significant ECE staining. Elevated levels of big ET-1 were measured in the
ECE/NEP-inhibited veins, consistent with reduced ECE activity. However, ma
ture ET-1 was still detectable in these segments.
Conclusion: There is a requirement for potent and selective inhibitors of E
CE to evaluate fully the potential therapeutic benefits of blocking ET-1 bi
osynthesis. The use of dual inhibitors complicates the interpretation of re
sults, because the observed response is likely to be a combination of both
ECE and NEP inhibition.